CDTX - Wutah pendapatan taunan sajrone rolas wulan kepungkur Cidara Therapeutics

Logo grafis Cidara Corp (CDTX)

Cidara Therapeutics (CDTX) management is undergoing a rigorous restructuring, seeking survival through new licensing agreements. The trailing twelve-month sales growth rate captures the results of this strategy, where the parameter value equals -100.00. Development relies on Cloudbreak automation to accelerate testing and a high level of authority in creating immunotherapies against dangerous infections.

Cidara Therapeutics, Inc. (CDTX) - Wutah dodolan YoY (TTM) saka 11.02.2024 nganti 17.01.2026

cidara.com (CDTX) - rincian metrik lan laporan keuangan

- kuotasi saiki lan rata-rata prakiraan nilai:
Pambiji fundamental perusahaan:Cidara Corp
Produk merek Cidara Therapeutics

This indicator measures rolling year revenue dynamics relative to the same period last year, allowing for an assessment of management's ability to contain operating expenses amid revenue growth. By analyzing the relative change in rolling year revenue versus the prior year period, an investor can identify risks of payroll inflation, which is critical for Cidara Therapeutics (CDTX) when receiving interim partnership payments from pharma behemoths.